Aandelen in “Farmaceutische producten: Andere”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Farmaceutische producten: Andere”

00:28 · Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman · Persbericht

00:28 · Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman · Persbericht

2/04 · Bel20 beperkt verlies op donkerrode beursdag · Tijd.be (€)

Daags na zijn beste dag in een jaar moet de Bel20 terrein prijsgeven na de speech van Trump, al doet de index het wel beter dan de Europese collega's. Argenx profiteert niet van een koopadvies. De min...

2/04 · Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression · Persbericht

1/04 · Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference · Persbericht

1/04 · Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman · Persbericht

1/04 · Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

1/04 · TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates · Persbericht

31/03 · Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 · Persbericht

31/03 · Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

31/03 · Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results · Persbericht

31/03 · Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 · Persbericht

30/03 · Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year · Persbericht

28/03 · Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC · Persbericht

26/03 · Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program · Persbericht

26/03 · BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) · Persbericht

25/03 · Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Corcept Therapeutics Incorporated(CORT) Shareholders · Persbericht

25/03 · TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates · Persbericht

24/03 · Paranovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules · Persbericht

24/03 · American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education · Persbericht

24/03 · Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice · Persbericht

Mijn selecties